Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

FDA grants rare pediatric disease designation to Kuros Biosciences' KUR-112

Oct. 21, 2016

Fujifilm Kyowa Kirin Biologics reports phase III results for adalimumab biosimilar FKB-327

Oct. 20, 2016

Two mutations at the same anticodon stem pair may cause different myopathic phenotypes

Oct. 20, 2016

Novel MYH7 mutation causes Laing distal myopathy

Oct. 19, 2016

Pfizer to begin shipping Inflectra next month

Oct. 18, 2016

DNAJB6 mutation is associated with myofibrillar myopathies

Oct. 17, 2016

Novel BICD2 mutations may cause SMALED2

Oct. 17, 2016

Akros initiates phase II trial of JTE-051 in active rheumatoid arthritis

Oct. 17, 2016

Novel SPEG gene mutation linked to centronuclear myopathy

Oct. 13, 2016

Meiji Seika opens phase I pharmacokinetic bioequivalence study of DMB-3113 and adalimumab in Japan

Oct. 11, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.